| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Physiology, Michigan State University, East Lansing, Michigan 48824
Primary cultures of rat
type II alveolar epithelial cells (AECs) or human AEC-derived A549
cells, when exposed to bleomycin (Bleo), exhibited
concentration-dependent apoptosis detected by altered nuclear
morphology, fragmentation of DNA, activation of caspase-3, and net cell
loss over time. In both cell culture models, exposure to Bleo caused
time-dependent increases in angiotensinogen (ANGEN) mRNA.
Antisense oligonucleotides against ANGEN mRNA inhibited Bleo-induced
apoptosis of rat AEC or A549 cells by 83 and 84%, respectively
(P < 0.01 and P < 0.05), and
prevented Bleo-induced net cell loss. Apoptosis of rat AECs or
A549 cells in response to Bleo was inhibited 91% by the ANG-converting
enzyme inhibitor captopril or 82%, respectively, by neutralizing
antibodies specific for ANG II (both P < 0.01).
Antagonists of ANG receptor AT1 (losartan, L-158809, or
saralasin), but not an AT2-selective blocker (PD-123319), inhibited Bleo-induced apoptosis of either rat AECs (79%,
P < 0.01) or A549 cells (83%, P < 0.01) and also reduced the activity of caspase-3 by 52%
(P < 0.05). These data indicate that Bleo, like
FasL or TNF-
, induces transactivation of ANG synthesis
de novo that is required for AEC apoptosis. They also support
the theory that ANG system antagonists have potential for the blockade of AEC apoptosis in situ.
renin-angiotensin system; type II pneumocyte; lung fibrosis; programmed cell death; angiotensinogen
This article has been cited by other articles:
|
|
 |
|
  B. D. Uhal The role of apoptosis in pulmonary fibrosis Eur. Respir. Rev., December 1, 2008; 17(109): 138 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Molina-Molina, A. Xaubet, X. Li, A. Abdul-Hafez, K. Friderici, K. Jernigan, W. Fu, Q. Ding, J. Pereda, A. Serrano-Mollar, et al. Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression Eur. Respir. J., October 1, 2008; 32(4): 1004 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Q. Haxhija, H. Yang, A. U. Spencer, H. Koga, X. Sun, and D. H. Teitelbaum Modulation of mouse intestinal epithelial cell turnover in the absence of angiotensin converting enzyme Am J Physiol Gastrointest Liver Physiol, July 1, 2008; 295(1): G88 - G98. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Li, M. Molina-Molina, A. Abdul-Hafez, V. Uhal, A. Xaubet, and B. D. Uhal Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L178 - L185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Li, M. Molina-Molina, A. Abdul-Hafez, J. Ramirez, A. Serrano-Mollar, A. Xaubet, and B. D. Uhal Extravascular sources of lung angiotensin peptide synthesis in idiopathic pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L887 - L895. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.B. J. Mancini, M. Etminan, B. Zhang, L. E. Levesque, J. M. FitzGerald, and J. M. Brophy Reduction of Morbidity and Mortality by Statins, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin Receptor Blockers in Patients With Chronic Obstructive Pulmonary Disease J. Am. Coll. Cardiol., June 20, 2006; 47(12): 2554 - 2560. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Y. Lee, C. Schroedl, J. K. Brunelle, L. J. Buccellato, O. I. Akinci, H. Kaneto, C. Snyder, J. Eisenbart, G. R. S. Budinger, and N. S. Chandel Bleomycin induces alveolar epithelial cell death through JNK-dependent activation of the mitochondrial death pathway Am J Physiol Lung Cell Mol Physiol, October 1, 2005; 289(4): L521 - L528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Krick, B. G. Eul, J. Hanze, R. Savai, F. Grimminger, W. Seeger, and F. Rose Role of Hypoxia-Inducible Factor-1{alpha} in Hypoxia-Induced Apoptosis of Primary Alveolar Epithelial Type II Cells Am. J. Respir. Cell Mol. Biol., May 1, 2005; 32(5): 395 - 403. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Li, R. Shu, G. Filippatos, and B. D. Uhal Apoptosis in lung injury and remodeling J Appl Physiol, October 1, 2004; 97(4): 1535 - 1542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Li, H. Rayford, R. Shu, J. Zhuang, and B. D. Uhal Essential role for cathepsin D in bleomycin-induced apoptosis of alveolar epithelial cells Am J Physiol Lung Cell Mol Physiol, July 1, 2004; 287(1): L46 - L51. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.J. Hoffmann Basic mechanisms of lung inflammation: executive summary of the first Lung Science Meeting of the European Respiratory Society at Taormina, Italy in 2003 Eur. Respir. J., September 20, 2003; 22(44_suppl): 1s - 3s. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
